Cardiology & Vascular Medicine: Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial

https://www.thelancet.com/collections/cardiology-vascular-medicine?parent=001536